A deficiency in the protein responsible for moving glucose across the brain's protective blood-brain barrier appears to intensify the neurodegenerative effects of Alzheimer's disease, according to a ...

A new study confirmed the validity of a blood test that can diagnose patients with GLUT1 deficiency syndrome, a treatable neurometabolic disease that causes a wide range of neurologic symptoms in ...

Glut1 deficiency syndrome is a rare and disabling neurological disease still relatively unknown to the medical community. A mutation in the SLC2A1 gene in affected patients causes the glucose ...

The glucose transporter GLUT1 at the blood-brain barrier (BBB) mediates glucose transport into the brain. Alzheimer's disease is characterized by early reductions in glucose transport associated with ...

Targeting and disabling a certain protein essential to transporting glucose properly through cells (Glucose Transporter 1, or Glut1) could be a new way to fight kidney disease, according to a study ...

Glucose is the primary source of energy and substrate for cells, and its uptake through the cell plasma membrane is largely dependent on the glucose transport (GLUT) family. GLUT1, one of the GLUT ...

Glut1 deficiency syndrome is a rare and disabling neurological disease still relatively unknown to the medical community. A mutation in the SLC2A1 gene in affected patients causes the glucose ...

A new study of non-diabetic women with ovarian cancer reveals a potential correlation and area for further study regarding the expression of the GLUT1 glucose transporter receptor at the cancer tissue ...

In three hours, Paul Shelsta would take the field for his first football game as offensive coordinator for the Hartford Union High School Orioles. That night in August 2016 was to be a big moment for ...

Risk factors which predict biopsy upgrading over time in active surveillance for prostate cancer. Impact of 68Ga-PSMA-11 PET on the management of biochemically recurrent prostate cancer in a ...